The DOI matches its Crossref record.
Mutations in Topoisomerase IV and DNA Gyrase of Staphylococcus aureus : Novel Pleiotropic Effects on Quinolone and Coumarin Activity
Abstract
Previous studies have shown that topoisomerase IV and DNA gyrase interact with quinolones and coumarins in different ways. The MICs of coumarins (novobiocin and coumermycin) for MT5, a Staphylococcus aureus nov mutant, are higher than those for wild-type strains. Sequencing the gyrB gene encoding one subunit of the DNA gyrase revealed the presence of a double mutation likely to be responsible for this resistance: at codon 102 (Ile to Ser) and at codon 144 (Arg to Ile). For single-step flqA mutant MT5224c9, previously selected on ciprofloxacin, the fluoroquinolone MIC was higher and the coumarin MIC was lower than those for its parent, MT5. Sequencing the grlB and grlA genes of topoisomerase IV of MT5224c9 showed a single Asn-470-to-Asp mutation in GrlB. Genetic outcrosses by transformation with chromosomal DNA and introduction of plasmids carrying either the wild-type or the mutated grlB gene indicated that this mutation causes both increased MICs of fluoroquinolones and decreased MICs of coumarins and that the mutant grlB allele is codominant for both phenotypes with multicopy alleles. Integration of these plasmids into the chromosome confirmed the codominance of fluoroquinolone resistance, but grlB + appeared dominant over grlB (Asp-470) for coumarin resistance. Finally, the gyrA (Leu-84) mutation previously described as silent for fluoroquinolone resistance increased the MIC of nalidixic acid, a nonfluorinated quinolone. Combining the grlA (Phe-80) and grlB (Asp-470) mutations with this gyrA mutation also had differing effects. The findings indicate that alterations in topoisomerases may have pleiotropic effects on different classes of inhibitors as well as on inhibitors within the same class. A full understanding of drug action and resistance at the molecular level must take into account both inhibitor structure-activity relationships and the effects of different classes of topoisomerase mutants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, efflux pumps, such as NorA, play a crucial role by actively expelling fluoroquinolones from bacterial cells, further enhancing resistance.”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [244]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 41
- 10.1093/nar/15.2.771 · doi:10.1093/nar/15.2.771
- Berger J. M. Gamblin S. J. Harrison S. C. Wang J. C. Structure and mechanism of DNA topoisomerase II. Nature 379 1996 225 232 · DOI · Paper page
- 10.1128/AAC.40.12.2714 · doi:10.1128/aac.40.12.2714
- 10.1128/AAC.41.1.175 · doi:10.1128/aac.41.1.175
- 10.1128/jb.175.11.3269-3277.1993 · doi:10.1128/jb.175.11.3269-3277.1993
- 10.1111/j.1365-2958.1992.tb00886.x · DOI
- del Castillo I. Vizan J. L. Rodriguez-Sainz M. C. Moreno F. An unusual mechanism for resistance to the antibiotic coumermycin A1. Proc. Natl. Acad. Sci. USA 88 1991 8860 8864 · DOI
- 10.1111/j.1365-2958.1994.tb00458.x · DOI · Paper page
- 10.1128/AAC.39.7.1554 · doi:10.1128/aac.39.7.1554
- 10.1073/pnas.73.12.4474 · DOI · Paper page
- 10.1111/j.1574-6968.1995.tb07810.x · doi:10.1111/j.1574-6968.1995.tb07810.x
- Gilbert E. J. Maxwell A. The 24kDa N-terminal sub-domain of the DNA gyrase B protein binds coumarin drugs. Mol. Microbiol. 12 1994 365 373 · DOI
- 10.1128/jb.173.2.642-648.1991 · DOI
- 10.1128/AAC.38.9.2014 · DOI · Paper page
- 10.1073/pnas.92.25.11801 · DOI · Paper page
- 10.1038/305709a0 · DOI · Paper page
- 10.1016/0378-1119(91)90399-V · DOI · Paper page
- 10.1128/jb.164.1.288-293.1985 · doi:10.1128/jb.164.1.288-293.1985
- 10.1002/j.1460-2075.1996.tb00483.x · DOI · Paper page
- Maxwell A. The interaction between coumarin drugs and DNA gyrase. Mol. Microbiol. 9 1993 681 686 · DOI · Paper page
- 10.1128/jb.177.14.4166-4170.1995 · doi:10.1128/jb.177.14.4166-4170.1995
- 10.1128/AAC.35.12.2562 · doi:10.1128/aac.35.12.2562
- 10.1128/AAC.38.6.1345 · DOI · Paper page
- 10.1128/AAC.40.8.1881 · DOI · Paper page
- 10.1128/AAC.35.11.2288 · doi:10.1128/aac.35.11.2288
- 10.1128/AAC.40.10.2321 · DOI · Paper page
- 10.1128/jb.178.14.4060-4069.1996 · doi:10.1128/jb.178.14.4060-4069.1996
- 10.1128/AAC.41.2.471 · DOI · Paper page
- 10.1128/jb.124.1.201-211.1975 · doi:10.1128/jb.124.1.201-211.1975
- 10.1128/AAC.41.5.1166 · doi:10.1128/aac.41.5.1166
- 10.1128/jb.172.12.7260-7262.1990 · DOI · Paper page
- 10.1128/jb.154.1.406-412.1983 · doi:10.1128/jb.154.1.406-412.1983
- 10.1128/AAC.40.4.1060 · doi:10.1128/aac.40.4.1060
- 10.1128/jb.141.3.1331-1339.1980 · doi:10.1128/jb.141.3.1331-1339.1980
- Thiara A. S. Cundliffe E. Cloning and characterization of a DNA gyrase B gene from Streptomyces sphaeroides that confers resistance to novobiocin. EMBO J. 7 1988 2255 2259 · doi:10.1002/j.1460-2075.1988.tb03065.x
- 10.1128/jb.173.18.5854-5860.1991 · doi:10.1128/jb.173.18.5854-5860.1991
- Wasserman R. A. Wang J. C. Mechanistic studies of amsacrine-resistant derivatives of DNA topoisomerase II. J. Biol. Chem. 269 1994 20943 20951 · doi:10.1016/s0021-9258(17)31913-0
- Wigley D. B. Davies G. J. Dodson E. J. Maxwell A. Dodson G. Crystal structure of an N-terminal fragment of the DNA gyrase B protein. Nature (London) 351 1991 624 629 · DOI · Paper page
- 10.1128/AAC.37.1.126 · DOI · Paper page
- 10.1128/AAC.40.5.1157 · doi:10.1128/aac.40.5.1157
- 10.1128/AAC.35.8.1647 · DOI · Paper page
Cited by
Mechanisms of Action of Antimicrobials: Focus on Fluoroquinolones
Hooper, D. C. (2001) · Clinical Infectious Diseases · doi:10.1086/319370 · Cited by 517
Self-citationMechanisms of fluoroquinolone resistance
Hooper, D. C. (1999) · Drug Resistance Updates · doi:10.1054/drup.1998.0068 · Cited by 488
Self-citationFluoroquinolone resistance among Gram-positive cocci
Hooper, D. C. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00369-9 · Cited by 320
Self-citationMode of Action of Fluoroquinolones
Hooper, D. C. (1999) · Drugs · doi:10.2165/00003495-199958002-00002 · Cited by 290
Self-citationStaphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms
Touaitia, R., Mairi, A., Ibrahim, N. A., Basher, N. S., Idres, T., & Touati, A. (2025) · Antibiotics · doi:10.3390/antibiotics14050470 · Cited by 273
Metadata
- Authors
- Fournier, B., & Hooper, D. C.
- Affiliations
- Infectious Disease Division and Medical Services, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114-2696
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1998-01
- Volume
- 42
- Issue
- 1
- Pages
- 121-128
- ISSN
- 0066-4804
- 1098-6596
- Cited by
- 70
- References
- 0
- Language
- en
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mutations in Topoisomerase IV and DNA Gyrase of Staphylococcus aureus : Novel Pleiotropic Effects on Quinolone and Coumarin Activity. https://app.cochat.ai/papers/10.1128/aac.42.1.121
- The paper
- Fournier, B., & Hooper, D. C. (1998). Mutations in Topoisomerase IV and DNA Gyrase of Staphylococcus aureus : Novel Pleiotropic Effects on Quinolone and Coumarin Activity. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.42.1.121
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.